Results 71 to 80 of about 5,006,170 (184)

Quantitative analysis of enhanced malignant and benign lesions on contrast-enhanced spectral mammography [PDF]

open access: yesThe British Journal of Radiology, 2018
Objective: To retrospectively analyze the quantitative measurement and kinetic enhancement among pathologically proven benign and malignant lesions using contrast-enhanced spectral mammography (CESM). Methods: We investigated the ...
Chih-Ying, Deng   +7 more
openaire   +2 more sources

Application of MR Cytometry in Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer: A Comparative Study

open access: yesJournal of Magnetic Resonance Imaging, Volume 64, Issue 5, Page 1346-1360, November 2026.
ABSTRACT Background MR cytometry imaging is developed to characterize in vivo microstructures. Its clinical value in predicting pathological complete response (pCR) after neoadjuvant chemotherapy (NAC) for breast cancer remains unknown. Purpose To implement MR cytometry to predict pCR for breast cancer and compare the performance of different ...
Jie Ding   +10 more
wiley   +1 more source

Radiation dose analysis of contrast-enhanced spectral mammography

open access: yesZhongguo aizheng zazhi, 2017
Background and purpose: Contrast-enhanced spectral mammography (CESM) is a new technology introduced in recent years, and a technique based on conventional mammography. The radiation dose of the CESM was analyzed by comparing the average gland dose (AGD)
沈茜刚, 周良平, 郑晓静
doaj  

Liquid Biopsy: Past, Present, and Future

open access: yesMedComm, Volume 7, Issue 11, November 2026.
Liquid biopsy has expanded from cancer genotyping to a broader strategy for probing both oncologic and nononcologic conditions through circulating analytes and multilayer molecular readouts. This review traces the field's past, present, and future—summarizing where liquid biopsy is most actionable today, why performance varies across contexts, and ...
Jiachen Liu   +8 more
wiley   +1 more source

Added Value of Contrast-Enhanced Spectral Mammography in Postscreening Assessment

open access: yesThe Breast Journal, 2016
To assess the value on diagnostic and treatment management of contrast-enhanced spectral mammography (CESM), as adjunct to mammography (MG) and ultrasound (US) in postscreening in a breast cancer unit for patients with newly diagnosed breast cancer or with suspicious findings on conventional imaging.
Anne-Marie, Tardivel   +6 more
openaire   +2 more sources

Model‐based image restoration targeting higher‐dose digital mammography: Impact on radiologists' detection of clustered microcalcifications

open access: yesMedical Physics, Volume 53, Issue 11, November 2026.
Abstract Background Image noise in digital mammography (DM) can obscure image details and reduce the detectability of clinically relevant findings such as microcalcifications. Purpose To present and evaluate an extended model‐based (MB) image restoration pipeline for DM that incorporates quantum, electronic, and structural noise components, as well as ...
Renann F. Brandão   +7 more
wiley   +1 more source

Effectiveness of spectral mammography in the detection of breast cancer as a complementary test after X-ray mammography [PDF]

open access: yes, 2021
Przeprowadzono ocenę badań 40 pacjentek z potwierdzonym rakiem piersi, u których wykonano mammografię klasyczną oraz mammografię spektralną. Stwierdzono większą efektywność w wykrywaniu oraz ocenie charakteru zmiany w przypadku zastosowania techniki ...
Warchoł, Ewelina
core  

Hydrogel‐Based 3D‐Printed Anthropomorphic Breast Phantom for Emulating Mechanical and Dielectric Properties of Mammary Tissue. Applications in Microwave Imaging

open access: yesAdvanced Functional Materials, Volume 36, Issue 82, 12 October 2026.
A 3D‐printable breast phantom is developed using patient‐derived MRI data and hydrogels that replicate the dielectric properties of healthy and cancerous tissues. Mechanical and dielectric characterization confirm its suitability for microwave imaging.
Carlos M. Andreu   +5 more
wiley   +1 more source

Human biomarker navigator

open access: yesiMeta, Volume 5, Issue 5, October 2026.
The Human Biomarker Navigator integrates the disease continuum, biomarker dynamics, cross‐organ biomarker networks, biomarker classification, and technology‐driven paradigms. It maps how biomarkers link multi‐system physiology and pathology across the nervous, respiratory, endocrine, circulatory, immune, digestive, urinary, reproductive, and ...
Meng‐Yao Li   +29 more
wiley   +1 more source

Contrast-enhanced Mammography: State of the Art

open access: yes, 2021
Contrast-enhanced mammography (CEM) has emerged as a viable alternative to contrast-enhanced breast MRI, and it may increase access to vascular imaging while reducing examination cost.
Lobbes, M.B.I.   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy